| Product Code: ETC8282437 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Lung Transplant Therapeutics Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Lung Transplant Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Lung Transplant Therapeutics Market - Industry Life Cycle |
3.4 Mexico Lung Transplant Therapeutics Market - Porter's Five Forces |
3.5 Mexico Lung Transplant Therapeutics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Mexico Lung Transplant Therapeutics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Mexico Lung Transplant Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 Mexico Lung Transplant Therapeutics Market Revenues & Volume Share, By Technique, 2021 & 2031F |
3.9 Mexico Lung Transplant Therapeutics Market Revenues & Volume Share, By Patient Demographics, 2021 & 2031F |
4 Mexico Lung Transplant Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lung diseases and respiratory disorders in Mexico. |
4.2.2 Technological advancements in lung transplant therapeutics. |
4.2.3 Growing awareness about lung transplant procedures and availability of treatment options. |
4.3 Market Restraints |
4.3.1 High cost associated with lung transplant therapeutics. |
4.3.2 Limited availability of donor organs for lung transplant procedures. |
4.3.3 Stringent regulatory requirements and lengthy approval processes for new therapeutics. |
5 Mexico Lung Transplant Therapeutics Market Trends |
6 Mexico Lung Transplant Therapeutics Market, By Types |
6.1 Mexico Lung Transplant Therapeutics Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Mexico Lung Transplant Therapeutics Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Mexico Lung Transplant Therapeutics Market Revenues & Volume, By Immunosuppressant Drugs, 2021- 2031F |
6.1.4 Mexico Lung Transplant Therapeutics Market Revenues & Volume, By Organ Preservation Products, 2021- 2031F |
6.1.5 Mexico Lung Transplant Therapeutics Market Revenues & Volume, By Tissue Products, 2021- 2031F |
6.2 Mexico Lung Transplant Therapeutics Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Mexico Lung Transplant Therapeutics Market Revenues & Volume, By Chronic Obstructive Pulmonary Diseases (COPD), 2021- 2031F |
6.2.3 Mexico Lung Transplant Therapeutics Market Revenues & Volume, By Pulmonary Fibrosis, 2021- 2031F |
6.2.4 Mexico Lung Transplant Therapeutics Market Revenues & Volume, By Septic Lung Disease, 2021- 2031F |
6.2.5 Mexico Lung Transplant Therapeutics Market Revenues & Volume, By Pulmonary Hypertension, 2021- 2031F |
6.2.6 Mexico Lung Transplant Therapeutics Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.2.7 Mexico Lung Transplant Therapeutics Market Revenues & Volume, By Interstitial Pulmonary Fibrosis, 2021- 2031F |
6.2.8 Mexico Lung Transplant Therapeutics Market Revenues & Volume, By Sarcoidosis, 2021- 2031F |
6.2.9 Mexico Lung Transplant Therapeutics Market Revenues & Volume, By Sarcoidosis, 2021- 2031F |
6.3 Mexico Lung Transplant Therapeutics Market, By Type |
6.3.1 Overview and Analysis |
6.3.2 Mexico Lung Transplant Therapeutics Market Revenues & Volume, By Cadaveric Lung Transplantation, 2021- 2031F |
6.3.3 Mexico Lung Transplant Therapeutics Market Revenues & Volume, By Living Lung Transplantation, 2021- 2031F |
6.4 Mexico Lung Transplant Therapeutics Market, By Technique |
6.4.1 Overview and Analysis |
6.4.2 Mexico Lung Transplant Therapeutics Market Revenues & Volume, By Single-Lung Transplantation, 2021- 2031F |
6.4.3 Mexico Lung Transplant Therapeutics Market Revenues & Volume, By Bilateral-Lung Transplantation, 2021- 2031F |
6.4.4 Mexico Lung Transplant Therapeutics Market Revenues & Volume, By Heart-Lung Transplantation, 2021- 2031F |
6.4.5 Mexico Lung Transplant Therapeutics Market Revenues & Volume, By Double Lung Transplantation, 2021- 2031F |
6.5 Mexico Lung Transplant Therapeutics Market, By Patient Demographics |
6.5.1 Overview and Analysis |
6.5.2 Mexico Lung Transplant Therapeutics Market Revenues & Volume, By Geriatric, 2021- 2031F |
6.5.3 Mexico Lung Transplant Therapeutics Market Revenues & Volume, By Adult, 2021- 2031F |
6.5.4 Mexico Lung Transplant Therapeutics Market Revenues & Volume, By Paediatric, 2021- 2031F |
7 Mexico Lung Transplant Therapeutics Market Import-Export Trade Statistics |
7.1 Mexico Lung Transplant Therapeutics Market Export to Major Countries |
7.2 Mexico Lung Transplant Therapeutics Market Imports from Major Countries |
8 Mexico Lung Transplant Therapeutics Market Key Performance Indicators |
8.1 Patient survival rate post lung transplant. |
8.2 Average waiting time for lung transplant surgery. |
8.3 Number of hospitals offering lung transplant services. |
8.4 Rate of adoption of new technologies in lung transplant procedures. |
8.5 Patient satisfaction and quality of life post lung transplant. |
9 Mexico Lung Transplant Therapeutics Market - Opportunity Assessment |
9.1 Mexico Lung Transplant Therapeutics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Mexico Lung Transplant Therapeutics Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Mexico Lung Transplant Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.4 Mexico Lung Transplant Therapeutics Market Opportunity Assessment, By Technique, 2021 & 2031F |
9.5 Mexico Lung Transplant Therapeutics Market Opportunity Assessment, By Patient Demographics, 2021 & 2031F |
10 Mexico Lung Transplant Therapeutics Market - Competitive Landscape |
10.1 Mexico Lung Transplant Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Mexico Lung Transplant Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here